Molecules / Carboprost

Carboprost API manufacturers

CAS 35700-23-3 ATC G02AD04 Updated 9 July 2026
5
manufacturers with an active filing 5 of them hold a US DMF or a CEP
49
finished-dose makers across 15 regulators
Showing 5 of 5 manufacturers This list is ranked on evidence. Placement cannot be purchased.

Ranked API manufacturers

01

MSN Laboratories

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF and one valid CEP for carboprost, filing since 2014. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 26 markets.

US DMF
1 active
CEP
1 valid
Last FDA inspection
2025 · VAI
GMP recognised in
26 markets
How this listing is sourced EDQM certificate database
FDA, List of Drug Master Files
View profile
02

EUROAPI

Hungary
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for carboprost, filing since 2021. Its 2019 FDA inspection closed as NAI, and its GMP is recognised in 1 market.

US DMF
1 active
CEP
None on file
Last FDA inspection
2019 · NAI
GMP recognised in
1 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
03

TIEN (Tianjin) Pharmaceutical

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for carboprost, filing since 2021. Its 2017 FDA inspection closed as NAI.

US DMF
1 active
CEP
None on file
Last FDA inspection
2017 · NAI
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
04

Chirogate International

Taiwan
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for carboprost, filing since 2019. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 1 market.

US DMF
1 active
CEP
None on file
Last FDA inspection
2025 · VAI
GMP recognised in
1 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
05

BrightGene Bio-Medical Technology

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for carboprost, filing since 2022. Its GMP is recognised in 1 market.

US DMF
1 active
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
1 markets
How this listing is sourced FDA, List of Drug Master Files
View profile

2 more manufacturers hold filings for carboprost

The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.

Chirogate InternationalBrightGene Bio-Medical Technology
Open the full list with a free account

Contract manufacturers (1)

Shree Venkatesh International India

Contract manufacturers make to order rather than holding their own filing for this molecule.

Finished-dose makers (16)

Dr. Reddy's Laboratories India Pfizer Brasil Ltda Brazil Amneal United States HIKMA ITALIA Italy Alembic Pharmaceuticals India Gland Pharma India Micro Labs India Pfizer United States ANI Pharmaceuticals United States Bharat Serums and Vaccines India Jamp Pharma Canada Unicorn Pharmaceuticals Pty South Africa Công ty Cổ phần Dược phẩm CPC1 Hà Nội Vietnam Công ty cổ phần dược phẩm Vĩnh Phúc (Vinphaco) Vietnam Pfizer Canada Ulc Canada Sunny Taiwan

How this list is built

The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.

Active US DMFs
FDA, List of Drug Master Files
Valid CEPs
EDQM certificate database
Inspection outcomes
FDA inspection classifications
GMP certificates
EudraGMDP and national regulators

Map carboprost for your markets

Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.

Start for free
No sales call.

Also on this molecule

Finished dose 16 Contract mfrs 1